Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling

ConclusionsThe findings of this study showed that the cancer patients have lower levels of vancomycin due to higher clearance than non ‐cancer patients. Thus, higher doses than the standard vancomycin doses may be needed to treat invasive Methicillin‐resistantStaphylococcus aureus infections in cancer patients.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - October 21, 2020 Category: Drugs & Pharmacology Authors: Saeed Alqahtani, Abdullah Almatrafi, Norah Bin Aydan, Meshari Alqahtani, Faisal Alzamil, Abdullah Alsultan, Yousif Asiri Tags: ORIGINAL RESEARCH ARTICLE Source Type: research